Purchases and Sales Made in Q3 2024 in Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP) during Q3 2024. The information is specifically focused on institutions that hold shares of CRISPR Therapeutics AG.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 07, 2024
Q3 2024
|
Nikko Asset Management Americas, Inc.
|
SELL
|
- |
-184K- 5.85% |
$8.22M - $11.6M
|
2.97M
$163M
|
|
|
Oct 31, 2024
Q3 2024
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
SELL
|
- |
-280K- 3.6% |
$12.5M - $17.6M
|
7.5M
$413M
|
|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-397K- 94.35% |
$17.7M - $24.9M
|
23.8K
$1.31M
|